Experience in using levodopa-benserazide
Levodopa remains the most effective drug for the treatment of Parkinson's disease. The paper considers the mechanism of action, recommended levodopa doses, the time of therapy initiation, and risk factors for motor complications. A few dosage forms of levodopa are currently being used. The resu...
Main Authors: | Elena Anatolyevna Katunina, Yu. N. Bezdolnyi, E. A. Malykhina, N. V. Titova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IMA-PRESS LLC
2015-10-01
|
Series: | Nevrologiâ, Nejropsihiatriâ, Psihosomatika |
Subjects: | |
Online Access: | https://nnp.ima-press.net/nnp/article/view/538 |
Similar Items
-
Betaine protects cerebellum from oxidative stress following levodopa and benserazide administration in rats
by: Masoud Alirezaei
Published: (2015-10-01) -
The relationship between the distinct ratios of benserazide and carbidopa to levodopa and motor complications in Parkinson's disease: A retrospective cohort study
by: Baba, Y., et al.
Published: (2022) -
Hepatoprotective Effects of Betaine Against Oxidative Stress Induced by Levodopa and Benserazide in Rats
by: M Alirezaei, et al.
Published: (2015-02-01) -
Clinical effect of levodopa and benserazide hydrochloride tables combined with visual occlusion for amblyopia in children
by: Li-Bing Yi, et al.
Published: (2018-11-01) -
Levodopa/Benserazide PLGA Microsphere Prevents L-Dopa–Induced Dyskinesia via Lower β-Arrestin2 in 6-Hydroxydopamine Parkinson’s Rats
by: Wen-Wen Wang, et al.
Published: (2019-06-01)